DalsnaFinance › IPOs › Actuate Therapeutics Inc › IPO

ACTUATE THERAPEUTICS, INC. IPO

Completed

ACTUATE THERAPEUTICS, INC. completed its initial public offering on NASDAQ on August 13, 2024, pricing at $8.00 a share.

Ticker	ACTU
Exchange	NASDAQ
Status	Completed
Listing date	August 13, 2024
Offering price	$8.00
Shares offered	2,800,000
Total raised	$22M

The offering

ACTUATE THERAPEUTICS, INC. sold 2,800,000 shares at $8.00 each on NASDAQ. Multiplied out, that is $22.4 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $22 million total recorded for the deal.

Company coverage

ACTUATE THERAPEUTICS, INC. — quote, profile and latest news →

Other recent IPOs

Iambic Therapeutics, Inc. · October 13, 2026
Retension Pharmaceuticals, Inc. · October 8, 2026
Frazier Life Sciences Acquisition Corp. II · October 8, 2026
TRex Bio, Inc. · October 6, 2026
Pine Tree Acquisition Corp. · October 5, 2026
Accelevation Holdings Corp. · September 30, 2026
Southport Acquisition Corp. II · September 30, 2026
ROZE AI INC. · September 28, 2026

Source: SEC EDGAR filings for ACTUATE THERAPEUTICS, INC.. This page is general information, not investment advice.